Effect of interferon-α treatment of chronic hepatitis C on health- related quality of life

Digestive Diseases and Sciences

Volumn 42, Issue 12, 1997, Pages 2482-2486

  Hunt, Christine M ^a   Dominitz, Jason A ^b   Bute, Barbara Philips ^b   Waters, Bradford ^b   Blasi, Umberto ^b   Williams, Diane M ^b  

^a Galxo Wellcome Inc   (United States)

^b NONE

Author keywords

Anxiety; Depression; Health status; Hepatitis C virus; Interferon alpha therapy; Quality of life

Indexed keywords

ALPHA INTERFERON; AMINOTRANSFERASE;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; ANXIETY NEUROSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; HEALTH STATUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; SCORING SYSTEM;

ADULT; ANXIETY; DEPRESSION; FEMALE; HEALTH STATUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED; QUALITY OF LIFE; TEST ANXIETY SCALE;

EID: 0031425275     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018852309885     Document Type: Article

References (18)

1. Sharara AI, Hunt CM, Hamilton JD: Medical progress in hepatitis C. Ann Intern Med 125:658-668, 1996
2. DiBisceglie A, Goodman ZD, Ishak KG, Hoofnagle JH, Melpolder JJ, Alter HJ: Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis. Hepatology 14:969-974, 1991
3. Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y, Furuta S, Akahane Y, Nishioka K, Purcell RH, Alter HJ: Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus. Hepatology 12:671-675, 1990
4. Renault PF, Hoofnagle JH: Side effects of alpha interferon. Semin Liver Dis 9:273-277, 1989
5. Tarlov AR, Ware JE Jr, Greenfield S, Nelson EC, Perrin E, Zubkoff M: Medical Outcomes Study: An application of methods for evaluating the results of medical care. JAMA 262:925-930, 1989
6. Ware JE Jr: SF-36 health survey: Manual and interpretation guide. Boston, The Health Institute, New England Center, 1994
7. Fryback DG, Dasbach EJ, Klein R, Klein BEK, Dorn N, Peterson K, Martin PA: The Beaver Dam health outcomes study: Initial catalog of health-state quality factors. Med Decis Making 13:89-102, 1993
8. Zigmond AS, Snaith RP: The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 67:361-370, 1983
9. Beck AT, Rush AJ, Shaw BF, Emery G: Cognitive therapy of depression. New York, Guilford Press, 1979
10. Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer HC, Perrillo RP, Carey W, Jacobson IM, Payne J, Dienstag JL, Van Thiel DH, Tamburro C, Martino FP, Sangvhi B, Albrecht JK: Assessing health-related quality of life in chronic hepatitis C using the Sickness Impact Profile. Clin Ther 16:334-343, 1994
11. Mulrow CD, Williams JW, Gerety MB, Ramirez G, Montiel OM, Kerber C: Case-finding instruments for depression in primary care settings. Ann Intern Med 122:913-921, 1995
12. Regier DA, Boyd JH, Burke JD, Rae DS, Myers JK, Kramer M, Robins LN, George LK, Karno M, Locke BZ: One-month prevalence of mental disorders in the United States. Arch Gen Psychiatry 45:977-986, 1988
13. Janssen HLA, Brouwer JT, van der Mast RC, Schalm SW: Suicide associated with alfa-interferon therapy for chronic viral hepatitis. J Hepatol 21:241-243, 1994
14. Merimsky O, Chaitchik S: Neurotoxicity of interferon-alpha. Anti-Cancer Drugs 3:567-570, 1992
15. Shiell A, Briggs A, Farrell G: The cost effectiveness of alpha interferon in the treatment of chronic active hepatitis C. Med J Aust 160:268-272, 1994
16. Brillanti S, Garson J, Foli M, Whitby K, Deaville R, Masci C, Miglioli M, Luigi B: A pilot study of combination therapy with ribavirin plus interferon-alfa for interferon alfa-resistant chronic hepatitis C. Gastroenterology 107:812-817, 1994
17. Iino S, Hino K, Kuroki T, Suzuki H, Yamamoto S: Treatment of chronic hepatitis C with high-dose interferon alpha-2b. Dig Dis Sci 38:612-618, 1993
18. Testa MA, Simonson DC: Assessment of quality-of-life outcomes. N Engl J Med 334:835-840, 1996